US Broker Ratings

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Navigating a 12.78% Potential Upside Amid Industry Challenges

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is a notable player in the biotechnology sector, focusing on the development of innovative solutions that facilitate drug therapies and..

Arcus Biosciences, Inc. (RCUS): Investor Outlook with a 51.78% Potential Upside

Arcus Biosciences, Inc. (NASDAQ: RCUS) presents a compelling opportunity for investors seeking exposure to the high-stakes world of biotechnology. With a market capitalization of $2.63 billion,..

Auna SA (AUNA) Stock Analysis: Healthcare Innovator with a 120% Upside Potential

Auna SA (AUNA), a key player in the healthcare sector, is making waves in the investment community with its remarkable potential upside of 120.84%. Based in..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Evaluating a 5.37% Potential Upside in the Healthcare Sector

Phibro Animal Health Corporation (NASDAQ: PAHC) has carved out a significant niche in the healthcare sector, focusing on animal health and mineral nutrition. With a market..

OrthoPediatrics Corp. (KIDS) Investor Outlook: Uncovering a 43% Potential Upside in the Pediatric Orthopedics Market

OrthoPediatrics Corp. (NASDAQ: KIDS), a notable player in the healthcare sector, is drawing significant attention from investors with its impressive potential upside of 43.11%, as suggested..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: A Biotech Play with Nearly 97% Potential Upside

For investors with an eye on promising biotech opportunities, Trevi Therapeutics, Inc. (NASDAQ: TRVI) presents a compelling case. Based in New Haven, Connecticut, this clinical-stage biopharmaceutical..

Enhabit, Inc. (EHAB) Investor Outlook: Analyzing the 17% Potential Upside in Healthcare

Enhabit, Inc. (NASDAQ: EHAB), a prominent player in the healthcare sector, offers essential home health and hospice services across the United States. With a market capitalization..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: A Biotech Gem with a 124% Upside Potential

Spyre Therapeutics, Inc. (SYRE), a clinical-stage biotechnology company, is drawing significant interest from investors due to its promising pipeline and the potential for substantial stock price..

Talkspace, Inc. (TALK) Stock Analysis: A 60% Upside Potential Sparks Investor Interest

Investors looking for opportunities in the rapidly evolving healthcare sector might find Talkspace, Inc. (NASDAQ: TALK) an intriguing proposition. As a prominent player in the health..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: A Biotech Star with 56% Upside Potential

Dianthus Therapeutics, Inc. (DNTH) is making waves in the biotechnology industry with its promising pipeline for treating severe autoimmune and inflammatory diseases. As a clinical-stage biotech..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: A Promising 52.38% Potential Upside in the Biotech Space

Tyra Biosciences, Inc. (TYRA), a burgeoning name in the biotechnology sector, has captured investor attention with its focus on precision medicine targeting fibroblast growth factor receptor..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating a 15.10% Revenue Growth in the Healthcare Sector

InnovAge Holding Corp. (NASDAQ: INNV), a prominent player in the healthcare sector, has been making waves with its impressive 15.10% revenue growth. Specializing in the Program..

Delcath Systems, Inc. (DCTH) Stock Analysis: A 172% Potential Upside in the Healthcare Sector

Delcath Systems, Inc. (NASDAQ: DCTH) emerges as a compelling option in the healthcare sector, particularly for investors eyeing the medical devices industry. With a market capitalization..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: A 97% Potential Upside Amidst Biotech Ventures

Praxis Precision Medicines, Inc (NASDAQ: PRAX), a promising player in the biotechnology sector, is making waves with its innovative approach to treating central nervous system (CNS)..

Avadel Pharmaceuticals (AVDL) Stock Analysis: Navigating a Complex Landscape with Strong Revenue Growth

Avadel Pharmaceuticals plc (NASDAQ: AVDL) presents a unique opportunity for investors interested in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Unveiling a 93% Upside Potential in Biotech

Investors in the biotechnology sector are always on the lookout for the next breakthrough, and LENZ Therapeutics, Inc. (NASDAQ: LENZ) might just be that opportunity. With..

Bicara Therapeutics Inc. (BCAX) Investor Outlook: Analyzing the 101% Potential Upside

Bicara Therapeutics Inc. (NASDAQ: BCAX) is catching the attention of investors with its remarkable potential upside of 101.31%. As a clinical-stage biopharmaceutical company headquartered in Boston,..

Syndax Pharmaceuticals, Inc. (SNDX) Stock Analysis: A Promising 124% Upside on the Horizon

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) stands out in the biotechnology industry not only for its innovative cancer therapies but also for its compelling growth potential. With..

Ardelyx, Inc. (ARDX) Stock Analysis: Unveiling a 107% Potential Upside with Strong Buy Ratings

Ardelyx, Inc. (NASDAQ: ARDX), a biotechnology company specializing in innovative treatments for unmet medical needs, stands out in the healthcare sector with a current market capitalization..

Keros Therapeutics, Inc. (KROS) Investor Outlook: Unveiling a 38% Potential Upside in Biotech

Keros Therapeutics, Inc. (NASDAQ: KROS), a clinical-stage biopharmaceutical innovator, has captured investor attention with its ambitious pipeline and an intriguing 38.23% potential upside based on analyst..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds